Text written in Basque and translated automatically by Elia without any subsequent editing. SEE ORIGINAL
Treatment against leukemia
2001/09/01 Elhuyar Zientzia Iturria: Elhuyar aldizkaria
The European Commission approves a new treatment against chronic leukemia: Monoclonal Antibody Macycampath™. Invented by scientists from the Universities of Oxford and Cambridge, it serves to treat the most common type of leukemia in adults, i.e. chronic B-cell leukemia. With this treatment, the antibody is first associated with a specific cancer white cell antigen, which is removed from the blood, bone marrow, and organs.
eu es fr en ca gl
Gai honi buruzko eduki gehiago
Elhuyarrek garatutako teknologia
